Cancer Clinical Trials | Maryland | Adventist HealthCare

Clinical Trials

Browse cancer clinical trials at Adventist HealthCare.

What’s a Clinical Trial?

A clinical trial is a research study that tests a new medical device, medication or other therapy before it’s widely available. The study is done to see if the treatment works safely. The results of the study help researchers learn better ways to prevent, detect or treat cancer.

Should I Participate in a Clinical Trial?

When you take part in a clinical trial, your health may improve from the treatment. But it may not, and you may have side effects. Talk to your doctor about the potential risks and benefits.

Expert Researchers

At Adventist HealthCare, your clinical trial will be led by a team of specialists made up of doctors, clinical research nurses, research associates and assistants who do more than 65 cancer studies each year.

Search Cancer Clinical Trials

Showing 1-10 of 30

Sorted By:

  • AZA-MDS-006 (Connect)

    Connect® MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

  • CANOPY-A USOR 17167

    Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Completely Resected Non-small Cell Lung Cancer

  • CheckMate 9KD USOR 17149

    The purpose of this study is to assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate cancer that has spread.

  • Genentech NSABP B-59

    A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo

  • Golden Biotech GHPanc-1-001

    A Phase I/II study to determine the maximum tolerated dose and to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of antroquinonol in combination with nab-paclitaxel and gemcitabine in first line metastatic pancreatic cancer.

  • MK-3475-158/KEYNOTE-158

    In this study, participants with multiple types of advanced solid tumors that have progressed on standard of care therapy will be treated with pembrolizumab.

  • MK-3475-756/KEYNOTE-756 USOR 17188

    Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage ER+/HER2- Breast Cancer

  • MK-3475-775-KEYNOTE-775 USOR 17197

    Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer

  • MK-3475-KEYNOTE-564 USOR 16251

    Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy, RCC Clear Cell Component

  • MOST

    Study to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia or myelofibrosis.

Talk to a Cancer Navigator

Request a free consultation today to learn about our services.

Request a Consult

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.